Catalent Biologics Content

  1. Unlock The Potential Of GPEx Lightning Accelerate Your HEK Cell Line Development 3/25/2026

    Discover how an advanced cell line development platform now supports HEK cells alongside CHO, enabling rapid, scalable production of complex biologics while saving up to 12 weeks on development timelines.

  2. Overcoming Hurdles In Protein Therapy Manufacturing 3/24/2026

    Learn how biopharmaceutical leaders address scalability, quality control, and regulatory challenges when manufacturing protein-based therapies at commercial scale.

  3. Achieving Rapid, High-Titer Expression For Next-Generation Biologics 3/24/2026

    Uncover how tunable expression technology achieves optimal chain pairing and high titers for complex biologics, from four-chain bispecifics to difficult-to-express proteins, using platform processes.

  4. Catalent Capabilities Update March 2026: Analytical Services 3/24/2026

    A biologics analytics leader showcases development, testing, and characterization capabilities, emphasizing quality, regulatory compliance, and integrated support from discovery to commercialization.

  5. Rapid Antibody Gene-To-Drug Substance 3/20/2026

    Accelerate your monoclonal antibody program with an integrated gene-to-drug substance platform that delivers GMP-ready material for IND submission and first-in-human studies while ensuring scalability and manufacturing readiness.

  6. Process Optimization For Monoclonal Antibody (mAb) Commercial Manufacturing 3/20/2026

    Get access to the tools and expertise needed to support process development for biologic therapies from the clinical trial phase to commercialization.

  7. Where Biologic Stability Programs Fail — And How ICH Q1 Can Help You Get It Right 3/3/2026

    This session highlights common late-stage risks and discusses how a stronger stability design can support confident IND, BLA, and long-term supply strategies.

  8. Contract GMP Biologics Analytical Services 7/28/2025

    Pedro Morales, Director, Scientific Advisor of Biologics Analytical Services, explores how Catalent delivers tailored solutions through deep expertise and advanced capabilities.

  9. Formulation Through Manufacturing Under One Roof 2/18/2025

    Partner with a CDMO that understands the unique challenges of emerging biopharma, providing expert guidance in formulation development, manufacturing, and regulatory navigation.

  10. Leveraging Advanced Tech, Proven Expertise From Cell Line Development And Beyond 1/28/2025

    Learn how our expertise and advanced capabilities provide customized analytical solutions that ensure quality, precision, and regulatory compliance for your biotherapeutics.